| Literature DB >> 35839094 |
Nanne Kort1, Patrick Stirling2, Peter Pilot3, Jacobus Hendrik Müller2.
Abstract
Robot-assisted total hip arthroplasty (THA), in comparison to conventional THA, improves radiographic outcomes, but it remains unclear whether it alters complication rates, clinical and functional outcomes, and implant survival. The purpose of this systematic overview was to summarize the findings of the most recent meta-analyses that compare clinical and surgical outcomes of robot-assisted versus conventional THA. Two readers independently conducted an electronic literature search, screening and data extraction from five electronic databases. Inclusion criteria were: meta-analyses evaluating robot-assisted versus conventional THA in terms of radiographic outcomes, clinical and functional scores, and complications and revision rates. The literature search returned 67 records, of which 14 were duplicates and 49 were excluded, leaving three meta-analyses published within the past two years for data extraction and analysis. The present overview of meta-analyses suggests that, compared to conventional THA (n = 3011), robot-assisted THA (n = 1813) improves component placement and reduces intraoperative complications. The overview also affirms that robot-assisted THA could extend surgery by 20 minutes, and increases risks of postoperative heterotopic ossification, dislocation, and revision. None of the meta-analyses found significant differences in clinical or functional scores between robot-assisted and conventional THA. Future studies and reviews should make a clear distinction between active and semi-active robotic assistance, address technology matureness, and describe the experience of surgeons with robotic assistance.Entities:
Year: 2021 PMID: 35839094 PMCID: PMC8693228 DOI: 10.1302/2058-5241.6.200121
Source DB: PubMed Journal: EFORT Open Rev ISSN: 2058-5241
Fig. 1Flowchart of the study selection procedure.
Note. THA, total hip arthroplasty; RA, robotic-assisted.
Characteristics of included studies
| Han et al, 2019[ | Karunaratne et al, 2019[ | Chen et al, 2018[ | |
|---|---|---|---|
| Journal |
|
|
|
| Population | THA | THA | THA |
| Intervention (robotic-assisted, hips) | 817 | 474 | 522 |
| Comparator (conventional, hips) | 1536 | 481 | 994 |
| Outcomes reported by ≥ 3 studies | |||
| Radiographic outcomes | yes | yes | |
| Clinical scores | yes | yes | yes |
| Complication and revision rates | yes | yes | |
| Operation time | yes | yes | |
| Follow-up (months, range) | (0–168) | (18–60) | (0–60) |
| Studies assessed | |||
| Total (unique inclusions) | 14 (5) | 8 (1) | 7 (0) |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| Robots | |||
| ROBODOC | 8 | 6 | 4 |
| CASPAR | 1 | 1 | 1 |
| MAKO | 5 | 1 | 2 |
| Countries | |||
| USA | 6 | 2 | 2 |
| Japan | 4 | 3 | 3 |
| Germany | 3 | 2 | 1 |
| Korea | 1 | 1 | 1 |
Note. THA, total hip arthroplasty; RCT, randomized controlled trial.
Evaluation of the quality of meta-analyses on RA THA using AMSTAR-2
| First author, year | Han et al, 2019[ | Karunarante et al, 2019[ | Chen et al, 2018[ |
|---|---|---|---|
| Intervention | THA | THA & TKA | THA |
| 1. Research questions and criteria included PICO | N | Y | Y |
| 2. Published review protocol prior (c) | N | Y | N |
| 3. Explained study design inclusion criteria | N | N | Y |
| 4. Comprehensive literature search strategy (c) | P | Y | P |
| 5. Performed study selection in duplicate | Y | Y | Y |
| 6. Performed data extraction in duplicate | Y | Y | Y |
| 7. Excluded studies listed and justified (c) | N | Y | N |
| 8. Included studies described in adequate detail | P | P | P |
| 9. Included studies assessed for RoB (c) | Y | Y | P |
| 10. Reported sources of funding for studies | N | N | N |
| 11. Appropriate methods for data synthesis (c) | N | N | N |
| 12. Assessed impact of RoB in each study | Y | Y | N |
| 13. Considered RoB when interpreting results (c) | N | Y | N |
| 14. Observed heterogeneity & impact explained | N | Y | N |
| 15. Investigated publication bias (c) | Y | Y | N |
| 16. Reported own conflict of interests & funding | Y | Y | Y |
| Number of critical weaknesses | 4 | 1 | 5 |
| Result (AMSTAR-2) | Critically low | Low | Critically low |
Note. THA, total hip arthroplasty; TKA, total knee arthroplasty; RA, robotic-assisted; AMSTAR-2, A MeaSurement Tool to Assess systematic Reviews; PICO, Population Intervention Comparator Outcome; RoB, risk of bias; c, critical.
Fig. 2Critical AMSTAR-2 domains for the assessment of the meta-analyses.
Note. AMSTAR-2, A MeaSurement Tool to Assess systematic Reviews; PICO, Population Intervention Comparator Outcome; RoB, risk of bias; c, critical.
All reported outcomes of THA using robotic assistance and conventional instrumentation
| Han et al, 2019[ | Karunaratne et al, 2019[ | Chen et al, 2018[ | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unit |
| Effect size | p-value | Favours |
| Effect size | p-value | Favours |
| Effect size | p-value | Favours | |
| Radiographic outcomes | |||||||||||||
| Cup inclination (degrees) | WMD | 4 | –2.47 | 0.003 | RA | ||||||||
| Cup anteversion (degrees) | WMD | 4 | –1.63 | 0.600 | |||||||||
| Stem alignment (degrees) | WMD | 6 | –0.40 | 0.020 | RA | ||||||||
| Cup safe zone Lewinnek | WOR | 4 | 11.05 | < 0.001 | CI | ||||||||
| Cup safe zone Callanan | WOR | 4 | 7.63 | < 0.001 | CI | ||||||||
| LLD (> 3 or > 10 mm) | WOR | 4 | 0.74 | 0.280 | |||||||||
| Clinical scores | |||||||||||||
| Pooled HHS, PMA & JOA score | WMD | 10 | 0.01 | 0.970 | 3 | 0.09 | 0.380 | ||||||
| Pooled mHHS and HHS | WMD | 4 | –2.90 | n.r. | |||||||||
| PMA score | WMD | 4 | 0.06 | 0.860 | 4 | –1.25 | n.r. | ||||||
| HHS | WMD | 4 | 0.04 | 0.980 | |||||||||
| Complications and revision | |||||||||||||
| Intraoperative complication | WOR | 9 | 0.32 | 0.006 | RA | 5 | 0.12 | < 0.0001 | RA | ||||
| Nerve palsy | WOR | 3 | 4.47 | 0.110 | |||||||||
| Thigh pain | WOR | 3 | 0.32 | 0.030 | RA | ||||||||
| Heterotopic ossification | WOR | 4 | 1.44 | 0.290 | 3 | 1.94 | 0.040 | CI | |||||
| Dislocation | WOR | 6 | 2.28 | 0.020 | CI | ||||||||
| Total complications | WOR | 7 | 0.83 | 0.480 | 5 | 0.43 | 0.030 | RA | |||||
| Revision rate | WOR | 3 | 2.88 | 0.030 | CI | ||||||||
| Operation time (minutes) | WMD | 8 | 20.72 | 0.002 | CI | 3 | 23.21 | 0.090 | |||||
Number of studies assessing an outcome.
Note. THA, total hip arthroplasty; RA, robotic-assisted; CI, conventional instrumentation; WMD, weighted mean difference; WOR, weighted odds ratio; HHS, Harris Hip Score; PMA, Postel-Merle d'Aubigné; JOA, Japanese Orthopaedic Association; mHHA, modified Harrris Hip Score; LLD, leg length discrepancy; n.r., not reported.